Floatz logo

CLOPIDOGREL

Aortic Valve Disorder

Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de QuebecSmall moleculePhase 4 / ApprovedDormant
BBB
74/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Aortic Valve Disorder cohort.

Asset / SponsorPhaseRating
Aspirin
Assistance Publique - Hôpitaux de Paris
Phase 4BBB
Apixaban
Assistance Publique - Hôpitaux de Paris
Phase 3B
Oxygen
Rigshospitalet, Denmark
N/AD
Exenatide
Rigshospitalet, Denmark
N/AD
Byetta
Rigshospitalet, Denmark
N/AD
NORMAL HUMAN SERUM ALBUMIN
Rigshospitalet, Denmark
N/AD

Same molecule, other indications

CLOPIDOGREL is also rated in:

myocardial infarctionActive
A
Indicative · Phase 4
81 / 100
View asset →
transient ischemic attackActive
BBB
Indicative · Phase 4
77 / 100
View asset →
peripheral arterial diseaseActive
BBB
Indicative · Phase 4
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →